Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : IMDS nasdaq bulletin board -- Ignore unavailable to you. Want to Upgrade?

To: gao seng who wrote (3481)	6/12/1999 11:12:00 PM
From: gao seng	Read Replies (1) \| Respond to of 4122

IMAGING DIAGNOSTIC PREMIERS 'CTLM' IN U.K. (The following is a reformatted version of a press release issued by Imaging Diagnostic Systems Inc.) IMAGING DIAGNOSTIC PREMIERS THE CTLM IN THE U.K. FT. Lauderdale, Fl, May 19, 1999--Imaging Diagnostic Systems Inc. (OTC: BB IMDS) announced today that the Company is exhibiting for the first time their CTLM at the MED X-RAY Conference in Birmingham, England May 17th thru May 20th 1999. The British Institute of Radiology and the College of Radiographers organized MED X-RAY. This medical conference is the largest U.K. technical exhibition for diagnostic and therapeutic radiology. The Conference attendance included members of radiology and other medical professionals. Imaging Diagnostic Systems has developed the CTLM, a patented laser based mammography system that utilizes proprietary computed algorithms to create contiguous cross sectional slice images of the breast without the use of compression or ionizing radiation. (IM) PN -END- -0- (CRL) May/19/ 99 11:25 \| quote.bloomberg.com sorry if this is a repost, I haven't seen this news release before, though. it follows nicely after watching the hearings yesterday, in which the fda the nci and congress were thoroughly lambasted by burton and others on the possibility of these orgs kowtowing to the medical institutions instead of searching for better treatments for cancer. their arguement was supported by british and other european alternative cancer treatments have been in use in europe for up to 20 years in some instances, yet the studies are totally ignored in this country. while nafta and the general agreement to talk and talk were pushed through, whereby we now import a large percentage of our meat from all over the world, we in effect trust them to grow our cows in a trustworthy manner, but we don't trust their medical testing procedures. que? the worst case was mistletoe, but also hypothermia treatment for prostate cancer and thermography were discussed as examples of how the europeans are using alternative treatments that have been scientificaly studied and shown to have medical benefit. i think this is a perfect backdrop for acceptance of the ctlm in europe.